Literature DB >> 14548468

Veterinary vaccines.

L A Babiuk1, A A Potter.   

Abstract

Vaccination of animals for the prevention of infectious diseases has been practised for a number of years with little change in product composition. Recent advances in molecular biology, pathogenesis and immunology have laid the groundwork for the development of a new generation of veterinary vaccines based on pure subunits as well as live vectored bacteria and viruses. Along with novel methods of antigen preparation, the use of new adjuvants and delivery systems will permit targeting of the appropriate immune response as well as offering flexibility in terms of vaccination protocols. These new technologies are also being applied to the development of vaccines to enhance animal productivity and to control reproduction.

Entities:  

Year:  1994        PMID: 14548468      PMCID: PMC7173300          DOI: 10.1016/0734-9750(94)90021-3

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  118 in total

Review 1.  Immunological adjuvants: a role for liposomes.

Authors:  G Gregoriadis
Journal:  Immunol Today       Date:  1990-03

2.  Expression of heterologous proteins in Escherichia coli.

Authors:  L Gold
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Immunization studies with attenuated strains of Bacillus anthracis.

Authors:  B E Ivins; J W Ezzell; J Jemski; K W Hedlund; J D Ristroph; S H Leppla
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus.

Authors:  P P Pastoret; B Brochier; B Languet; I Thomas; A Paquot; B Bauduin; M P Kieny; J P Lecocq; J De Bruyn; F Costy
Journal:  Vet Rec       Date:  1988-11-05       Impact factor: 2.695

Review 5.  Potential of polymer microencapsulation technology for vaccine innovation.

Authors:  W Morris; M C Steinhoff; P K Russell
Journal:  Vaccine       Date:  1994-01       Impact factor: 3.641

6.  Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.

Authors:  S Kit; M Sheppard; H Ichimura; M Kit
Journal:  Am J Vet Res       Date:  1987-05       Impact factor: 1.156

7.  An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies.

Authors:  D J Evans; J McKeating; J M Meredith; K L Burke; K Katrak; A John; M Ferguson; P D Minor; R A Weiss; J W Almond
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

8.  Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

Authors:  B Morein; B Sundquist; S Höglund; K Dalsgaard; A Osterhaus
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

9.  Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor.

Authors:  R Barnard; P G Bundesen; D B Rylatt; M J Waters
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

10.  Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.

Authors:  M J Redmond; M K Ijaz; M D Parker; M I Sabara; D Dent; E Gibbons; L A Babiuk
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.